Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).
Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way.
Job Description
The Senior Director, Compensation Partner will play a key strategic role in shaping and driving Madrigal’s pay philosophy and compensation strategy across the organization. This leader will partner closely with HR Business Partners and line leadership to design, implement, and communicate compensation programs that enable us to attract, motivate, and retain exceptional talent while reinforcing our culture of performance, accountability, and purpose.
This role requires a balance of strategic vision and hands-on execution, with the ability to translate data and market insights into practical solutions that support business growth and employee engagement.
Key Responsibilities
- Strategic Partnership: Collaborate with HR Business Partners and business leaders to provide expert guidance on compensation strategies aligned with Madrigal’s talent and business objectives.
- Program Design & Execution: Lead the design and administration of competitive base pay, short-term incentive, and long-term equity programs that reinforce our pay-for-performance philosophy.
- Pay Philosophy Stewardship: Champion and evolve Madrigal’s pay philosophy, ensuring consistency, fairness, and transparency in compensation decisions.
- Market Analysis: Oversee benchmarking and market pricing processes to ensure compensation practices remain competitive and equitable.
- Business Advisory: Serve as a trusted advisor to senior leadership, providing data-driven insights to support organizational decisions on pay structures, promotions, and workforce planning.
- Governance & Compliance: Ensure all compensation programs comply with applicable laws, regulations, and internal governance standards.
- Communication & Education: Partner with the HR Business Partner community to educate managers and employees on compensation principles, helping build understanding and trust around our pay practices.
- Continuous Improvement: Identify opportunities to streamline processes, leverage technology, and enhance total rewards delivery to improve the employee experience.
- Other duties as assigned.
Required & Desired Qualifications
- Bachelor’s degree required
- 15+ years of progressive compensation experience, including at least 5 years in a leadership or business partner capacity.
- Deep knowledge of compensation design, market analysis, and job architecture.
- Proven experience advising senior leaders and influencing strategic decisions relating to compensation activities.
- Strong analytical skills with the ability to interpret complex compensation data and communicate actionable insights.
- Excellent collaboration and communication skills, with a track record of building strong cross-functional relationships.
- Experience in the pharmaceutical or biotech industry preferred.
- Some travel is required.
Madrigal’s Total Rewards strategy is based on a biotech industry peer group comparator and is inclusive of base pay, bonus and equity. Our equity offers meaningful opportunity allowing our employees to share in the success they help create. By aligning individual and company performance, we empower employees to think like owners, giving them a stake in the organization.
All employees receive equity, which we believe reinforces our ownership culture. Base salary is determined by several factors including the candidate’s qualifications, skills, education, experience, business needs and market demands. As of the date of this posting, a good faith estimate of the current pay scale for this position, applicable to all candidates, is $252,000 - $308,000 per year. We comply with all applicable minimum wage laws.
All full-time employees receive equity, which reinforces our ownership culture and offers meaningful opportunity for our employees to share in the success they help create. By aligning individual and company performance, we empower employees to think like owners, giving them a stake in the organization. Full-time employees are also eligible for comprehensive benefits, including flexible paid time off, medical, dental, vision and life/disability insurance, and 401(k) offerings (i.e., traditional, Roth, and employer match) in accordance with applicable plans. We also offer additional voluntary benefits like supplemental life insurance, legal services, and other offerings. In addition, we offer mental health benefits through our Employee Assistance Program for employees and their family. The company also provides other benefits in accordance with applicable federal, state, and local laws. We are committed to providing reasonable accommodations for individuals with disabilities throughout the hiring process. If you need assistance, please contact [email protected]. Madrigal is an Equal Opportunity Employer. All employment is decided on the basis of qualifications, merit, and business need. Applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected by applicable federal, state, or local law. Unsolicited resumes from agencies should not be forwarded to Madrigal. Madrigal will not be responsible for any fees arising from the use of resumes through this source. Madrigal will only pay a fee to agencies if a formal agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through our Madrigal Careers site. Please be aware that we have received reports of individuals misrepresenting themselves as Madrigal Pharmaceuticals’ Hiring Managers, seeking to engage with job candidates through fraudulent online advertisements or job posting sites. These unauthorized individuals are using Madrigal’s name and logo in an attempt to solicit up-front fees and obtain personal information from interested job candidates. Please know that Madrigal does not conduct interviews via text or in chat rooms; conduct interviews via Skype, RingCentral or solely via telephone; charge candidates an advance fee of any kind (e.g., fees for purchasing equipment); nor does it offer positions of employment without undergoing a thorough recruiting process. Please also note that any correspondence with regard to employment would come from an authorized madrigalpharma.com email address or from an email address from one of our trusted search firm partners. We are aware that incorrect/fraudulent email addresses, with Madrigal misspelled, have been utilized in these most recent fraud attempts. If you receive unsolicited employment offers from people claiming to work for or on behalf of Madrigal, we recommend that you: do not respond to their questions; do not open any attachments; and do not click on any hyperlinks. Any questions regarding the legitimacy of job-related contacts can be directed to [email protected].
What We Do
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com
